Related Experiment Video

Updated: May 27, 2026

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
11:01

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase

Published on: November 23, 2016

Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine

Puppala Muthenna1, Chandrasekhar Akileshwari, G Bhanuprakash Reddy

  • 1Biochemistry Division, National Institute of Nutrition, Tarnaka, Hyderabad 500 604, India.

The Biochemical Journal
|November 9, 2011
PubMed

Insights

Ellagic acid (EA) effectively inhibits advanced glycation end-products (AGEs) formation, a key factor in diabetes complications. This flavonoid shows significant potential as an antiglycating agent for managing AGE-related pathologies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nutritional Science

Background:

  • Non-enzymatic glycation leads to advanced glycation end-products (AGEs) accumulation.
  • AGEs are implicated in aging and diabetic complications, exacerbated by hyperglycemia.
  • Understanding AGE inhibition mechanisms is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the AGE-inhibiting potential of ellagic acid (EA), a dietary flavonoid.
  • To elucidate the mechanism of action of EA as an antiglycating agent.
  • To assess EA's efficacy in preventing glycation-related protein damage and its physiological relevance.

Main Methods:

  • EA's inhibition of AGE formation was tested on various proteins (TSP, Hb, lysozyme, BSA) with different glycating agents (fructose, ribose, methylglyoxal).
  • Complementary methods, including MALDI-TOF-MS, were used to analyze AGE inhibition and specific adducts like Nϵ-(carboxyethyl)lysine (CEL).
  • Ex vivo studies assessed EA's effect on glycosylated hemoglobin and in vitro lens organ culture evaluated its impact on lens transparency.

Main Results:

  • EA demonstrated significant inhibition of AGE formation across multiple protein and glycating agent combinations.
  • EA primarily inhibited Nϵ-(carboxyethyl)lysine (CEL) formation, suggesting a role in scavenging dicarbonyl compounds.
  • EA prevented glycation-induced β-sheet formation in proteins and reduced glycosylated hemoglobin in human blood.
  • EA protected eye lens transparency in organ culture by inhibiting AGEs.

Conclusions:

  • Ellagic acid exhibits potent antiglycating properties by inhibiting AGE formation, particularly CEL.
  • EA's mechanism involves scavenging dicarbonyl compounds and preventing protein structural changes.
  • EA demonstrates physiological potential for managing AGE-mediated pathologies, including diabetic complications and cataracts.

More Related Videos

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...